Crestline Management, L.P.

← Tracker

Institutional

CIK 0001536054

$46.3M

Reported AUM

Positions

Q1 2026

Period

2026-05-15

Filed

The Brief · Crestline Management, L.P. · Q1 2026

AI · grounded in 13F

Crestline Management, L.P. reduced its position in SANA by 38.102%. The fund also trimmed its holding in DNLI by 21.3468%. Conversely, the manager slightly accumulated shares of EGHT by 0.0273%.

Portfolio · Q1 2026

Top holdings

QoQ vs Q4 2025

#	Ticker	Issuer	Value	% of book	Δ shares (QoQ)	Status
1	DNLI	DENALI THERAPEUTICS INC	$42.4M	91.74%	-600,000	-21.3%
2	SANA	SANA BIOTECHNOLOGY INC	$2.2M	4.70%	-465,201	-38.1%
3	EGHT	8X8 INC NEW	$1.6M	3.56%	+270	+0.0%

Source: SEC EDGAR · accession 0001315863-26-000412. 13F discloses long positions only — shorts, foreign equities, and options are excluded.